TY  - JOUR
A1  - Lötsch, Jörn
A1  - Hintschich, Constantin Andreas
A1  - Petridis, Petros
A1  - Pade, Jürgen
A1  - Hummel, Thomas
T1  - Machine-learning points at endoscopic, quality of life, and olfactory parameters as outcome criteria for endoscopic paranasal sinus surgery in chronic rhinosinusitis
T2  - Journal of Clinical Medicine
N2  - Chronic rhinosinusitis (CRS) is often treated by functional endoscopic paranasal sinus surgery, which improves endoscopic parameters and quality of life, while olfactory function was suggested as a further criterion of treatment success. In a prospective cohort study, 37 parameters from four categories were recorded from 60 men and 98 women before and four months after endoscopic sinus surgery, including endoscopic measures of nasal anatomy/pathology, assessments of olfactory function, quality of life, and socio-demographic or concomitant conditions. Parameters containing relevant information about changes associated with surgery were examined using unsupervised and supervised methods, including machine-learning techniques for feature selection. The analyzed cohort included 52 men and 38 women. Changes in the endoscopic Lildholdt score allowed separation of baseline from postoperative data with a cross-validated accuracy of 85%. Further relevant information included primary nasal symptoms from SNOT-20 assessments, and self-assessments of olfactory function. Overall improvement in these relevant parameters was observed in 95% of patients. A ranked list of criteria was developed as a proposal to assess the outcome of functional endoscopic sinus surgery in CRS patients with nasal polyposis. Three different facets were captured, including the Lildholdt score as an endoscopic measure and, in addition, disease-specific quality of life and subjectively perceived olfactory function.
Y1  - 2021
UR  - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/63395
UR  - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-633956
SN  - 2077-0383
VL  - 10
IS  - 18, art. 4245
SP  - 1
EP  - 26
PB  - MDPI
CY  - Basel
ER  -